Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content


Target population: Patients with Parkinson's Disease, Chorea, Atypical Parkinson syndromes/Parkinson Plus 

Measures:  Speech 

Clinical support:  Monitoring 

Redenlab’s field-leading technology enhances decision making in clinical trials by providing objective and meaningful measurement of speech and language in the clinic and at home. It is based on 15+ years of cutting-edge clinical research and more than 200 peer-reviewed studies. 
The Redenlab software suite utilizes cutting-edge audio capture and storage methods alongside pharmaceutical industry grade quality management systems designed to meet the strict privacy and data sovereignty requirements of the health and medical clinical trial environment. It provides capacity for onboarding patients and study subjects, integration with Redenlab’s cloud-based data management portal, study, site and session selection based on user requirements. 

Languages:  English, French, German, Dutch, Polish, Portuguese, Spanish, Italian 

Platform:  Desktop, Tablet, Mobile Phone (iPhone, Android, Other)

User interfaces:  Patients, Research study personnel, Doctors, Therapists 

Additional Features:

  • Unlimited amount of subjects 
  • Control data available
  • Database generation
  • Storage on Amazon Web Services (AWS), North America 
  • Data ownership determined by conditions of use
  • Support for usage/test-setting/analysis. Additional cost.


For more information:

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice